Search results
Added:
1 month ago
SCAI 2025 - Outcomes from prosthesis-patient mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI) show higher rates of severe predicted and measured PPM in female patients compared to male patients; however, PPM did not affect the five-year survival in women.Dr Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano, US) joins us to discuss the incidence and…
View more
Added:
6 days ago
Added:
6 months ago
Moderator Prof Flavio Ribichini (University of Verona, IT) is joined by Dr Hendrik Ruge (German Heart Center Munich, DE), Dr Philipp Bartko (Vienna General Hospital, AT), Dr Stephen Dorman (Bristol Heart Institute, UK) and Dr Nihal Wilde (Bundeswehr Central Hospital, DE), they focus on contemporary lifetime management in transcatheter aortic valve implantation (TAVI).Faculty explore the evolving…
View more
Added:
6 months ago
Start date:
Dec 05, 2024
Moderator Prof Flavio Ribichini (University of Verona, IT) is joined by Dr Hendrik Ruge (German Heart Center Munich, DE), Dr Philipp Bartko (Vienna General Hospital, AT), Dr Stephen Dorman (Bristol Heart Institute, UK) and Dr Nihal Wilde (Bundeswehr Central Hospital, DE) in this one hour webinar focusing on contemporary lifetime management in transcatheter aortic valve implantation (TAVI).Faculty…
View more
Added:
1 year ago
Added:
1 year ago
Dr Rayyan Hemetsberger(Medical University of Vienna, AT) led several patient-level analyses of pooled data from the BIOFLOW-II,-IV and -V trials, comparing the Orsiro DES to the Xience DES. In this interview, he presents the results of his analysis for complex vs. non-complex PCI patients. Further insights on other patient level analysis (calcified lesions, atherothrombotic risk patients) and his…
View more
Added:
9 months ago
One-year outcomes from INFINITY-SWEDEHEART RCT recently presented at ESC 2024 demonstrated that DynamX Bioadaptor meets primary endpoint and significantly reduces adverse events compared to DES after six months. Dr David Erlinge, the primary investigator of INFINITY-SWEDEHEART RCT, shares a quick summary of the one-year outcomes presented at ESC 2024. He highlights how the novel design and…
View more
Added:
1 year ago
EuroPCR 24 - We are joined onsite by Prof Ole De Backer (Rigshospitalet, DK) to discuss the findings from the NOTION-2 Study. (NCT02825134).NOTION-2 is a randomized, multicenter trial which aimed to investigate transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in 376 patients under 75 years of age with severe aortic valve stenosis in regard to intra-…
View more
Added:
3 weeks ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent…
View more
